Print Save or Share

Gepirone ER Approval Status beta

  • FDA approved: No
  • Generic name: Gepirone ER
  • Company: Fabre-Kramer Pharmaceuticals Inc. and GlaxoSmithKline
  • Treatment for: Depression

Gepirone extended-release (ER) is an investigational treatment for the treatment of adults with major depressive disorder.

FDA Approval Status for Gepirone ER

DateArticle
Nov  5, 2007Fabre Kramer Pharmaceuticals Receives Decision From FDA on Gepirone ER for Major Depressive Disorder
May  8, 2007Fabre-Kramer Refiles Gepirone ER with the FDA for the Treatment of Major Depressive Disorder

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Advertisement
Close

Recommended

(web4)